NCT05968599 2026-02-25
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Pfizer
Completed
Clinical Trials
11 trialsNCT07376057 2026-01-29
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not yet recruiting
NCT04962919 2025-02-11
LACOG 1818
Latin American Cooperative Oncology Group
Active not recruiting
NCT05520138 2024-09-27
Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)
Pfizer
Completed
NCT04833517 2022-12-08
Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)
Universität des Saarlandes
Unknown
NCT02398526 2021-11-02
PARABO
Bayer
Completed
NCT02450812 2021-11-02
URANIS
Bayer
Completed
NCT03563014 2020-05-20
BELFIGO
Bayer
Completed
NCT02899104 2020-03-31
Navigant
Bayer
Completed
NCT04126915 2019-11-05
PTtWES
Changhai Hospital
Unknown
NCT03325127 2018-10-31
Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study
Bayer
Withdrawn